APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sophorolipid and Rhamnolipid

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sophorolipid and Rhamnolipid Market Outlook and Growth Opportunities 2026

28 December 2025192 pages

Choose your research edition.

Industry ResearchSophorolipid and Rhamnolipid Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Sophorolipid and Rhamnolipid Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Sophorolipid and Rhamnolipid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sophorolipid and Rhamnolipid Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Sophorolipid and Rhamnolipid Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Sophorolipid and Rhamnolipid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sophorolipid and Rhamnolipid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sophorolipid and Rhamnolipid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sophorolipid and Rhamnolipid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sophorolipid and Rhamnolipid market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sophorolipid and Rhamnolipid market include Allied Carbon Solutions, Saraya, Evonik Industries, Givaudan, Godrej Industries, Holiferm, Stepan, Jeneil Bioproducts GmbH and Shanxi Deguan Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sophorolipid and Rhamnolipid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sophorolipid and Rhamnolipid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sophorolipid and Rhamnolipid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sophorolipid and Rhamnolipid market size, projected growth trends, production technologies, key applications, and end-use industries.

Sophorolipid and Rhamnolipid Segment by Company

Allied Carbon Solutions

Saraya

Evonik Industries

Givaudan

Godrej Industries

Holiferm

Stepan

Jeneil Bioproducts GmbH

Shanxi Deguan Biotechnology

Shandong Qilu Biotechnology

Sophorolipid and Rhamnolipid Segment by Type

Sophorolipid

Rhamnolipid

Sophorolipid and Rhamnolipid Segment by Application

Household Detergents

Personal Care

Industrial

Food & Beverage

Pharmaceuticals

Others

Sophorolipid and Rhamnolipid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sophorolipid and Rhamnolipid status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sophorolipid and Rhamnolipid market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sophorolipid and Rhamnolipid significant trends, drivers, influence factors in global and regions.

6. To analyze Sophorolipid and Rhamnolipid competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sophorolipid and Rhamnolipid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sophorolipid and Rhamnolipid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sophorolipid and Rhamnolipid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sophorolipid and Rhamnolipid market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sophorolipid and Rhamnolipid industry.

Chapter 3: Detailed analysis of Sophorolipid and Rhamnolipid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sophorolipid and Rhamnolipid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sophorolipid and Rhamnolipid in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sophorolipid and Rhamnolipid Industry Trends Table 2. Sophorolipid and Rhamnolipid Industry Drivers Table 3. Sophorolipid and Rhamnolipid Industry Opportunities and Challenges Table 4. Sophorolipid and Rhamnolipid Industry Restraints Table 5. Global Sophorolipid and Rhamnolipid Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sophorolipid and Rhamnolipid Revenue Share by Company (2021-2026) Table 7. Global Sophorolipid and Rhamnolipid Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Sophorolipid and Rhamnolipid Sales Volume Share by Company (2021-2026) Table 9. Global Sophorolipid and Rhamnolipid Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Sophorolipid and Rhamnolipid Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sophorolipid and Rhamnolipid Key Company Manufacturing Base & Headquarters Table 12. Global Sophorolipid and Rhamnolipid Company, Product Type & Application Table 13. Global Sophorolipid and Rhamnolipid Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sophorolipid and Rhamnolipid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Sophorolipid Table 18. Significant Companies of Rhamnolipid Table 19. Global Sophorolipid and Rhamnolipid Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Sophorolipid and Rhamnolipid Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Sophorolipid and Rhamnolipid Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Sophorolipid and Rhamnolipid Sales Volume Share by Type (2021-2026) Table 23. Global Sophorolipid and Rhamnolipid Sales Volume Share by Type (2027-2032) Table 24. Global Sophorolipid and Rhamnolipid Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sophorolipid and Rhamnolipid Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Sophorolipid and Rhamnolipid Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Sophorolipid and Rhamnolipid Sales Value Share by Type (2021-2026) Table 28. Global Sophorolipid and Rhamnolipid Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Household Detergents Table 30. Significant Companies of Personal Care Table 31. Significant Companies of Industrial Table 32. Significant Companies of Food & Beverage Table 33. Significant Companies of Pharmaceuticals Table 34. Significant Companies of Others Table 35. Global Sophorolipid and Rhamnolipid Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 36. Global Sophorolipid and Rhamnolipid Sales Volume by Application (2021-2026) & (Tons) Table 37. Global Sophorolipid and Rhamnolipid Sales Volume by Application (2027-2032) & (Tons) Table 38. Global Sophorolipid and Rhamnolipid Sales Volume Share by Application (2021-2026) Table 39. Global Sophorolipid and Rhamnolipid Sales Volume Share by Application (2027-2032) Table 40. Global Sophorolipid and Rhamnolipid Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Sophorolipid and Rhamnolipid Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Sophorolipid and Rhamnolipid Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Sophorolipid and Rhamnolipid Sales Value Share by Application (2021-2026) Table 44. Global Sophorolipid and Rhamnolipid Sales Value Share by Application (2027-2032) Table 45. Global Sophorolipid and Rhamnolipid Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 46. Global Sophorolipid and Rhamnolipid Sales by Region (2021-2026) & (Tons) Table 47. Global Sophorolipid and Rhamnolipid Sales Market Share by Region (2021-2026) Table 48. Global Sophorolipid and Rhamnolipid Sales by Region (2027-2032) & (Tons) Table 49. Global Sophorolipid and Rhamnolipid Sales Market Share by Region (2027-2032) Table 50. Global Sophorolipid and Rhamnolipid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Sophorolipid and Rhamnolipid Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Sophorolipid and Rhamnolipid Sales Value Share by Region (2021-2026) Table 53. Global Sophorolipid and Rhamnolipid Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Sophorolipid and Rhamnolipid Sales Value Share by Region (2027-2032) Table 55. Global Sophorolipid and Rhamnolipid Market Average Price (US$/Ton) by Region (2021-2026) Table 56. Global Sophorolipid and Rhamnolipid Market Average Price (US$/Ton) by Region (2027-2032) Table 57. Global Sophorolipid and Rhamnolipid Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 58. Global Sophorolipid and Rhamnolipid Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Sophorolipid and Rhamnolipid Sales by Country (2021-2026) & (Tons) Table 60. Global Sophorolipid and Rhamnolipid Sales Market Share by Country (2021-2026) Table 61. Global Sophorolipid and Rhamnolipid Sales by Country (2027-2032) & (Tons) Table 62. Global Sophorolipid and Rhamnolipid Sales Market Share by Country (2027-2032) Table 63. Global Sophorolipid and Rhamnolipid Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Sophorolipid and Rhamnolipid Sales Value Market Share by Country (2021-2026) Table 65. Global Sophorolipid and Rhamnolipid Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Sophorolipid and Rhamnolipid Sales Value Market Share by Country (2027-2032) Table 67. Allied Carbon Solutions Company Information Table 68. Allied Carbon Solutions Business Overview Table 69. Allied Carbon Solutions Sophorolipid and Rhamnolipid Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Allied Carbon Solutions Sophorolipid and Rhamnolipid Product Portfolio Table 71. Allied Carbon Solutions Recent Development Table 72. Saraya Company Information Table 73. Saraya Business Overview Table 74. Saraya Sophorolipid and Rhamnolipid Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Saraya Sophorolipid and Rhamnolipid Product Portfolio Table 76. Saraya Recent Development Table 77. Evonik Industries Company Information Table 78. Evonik Industries Business Overview Table 79. Evonik Industries Sophorolipid and Rhamnolipid Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Evonik Industries Sophorolipid and Rhamnolipid Product Portfolio Table 81. Evonik Industries Recent Development Table 82. Givaudan Company Information Table 83. Givaudan Business Overview Table 84. Givaudan Sophorolipid and Rhamnolipid Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Givaudan Sophorolipid and Rhamnolipid Product Portfolio Table 86. Givaudan Recent Development Table 87. Godrej Industries Company Information Table 88. Godrej Industries Business Overview Table 89. Godrej Industries Sophorolipid and Rhamnolipid Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Godrej Industries Sophorolipid and Rhamnolipid Product Portfolio Table 91. Godrej Industries Recent Development Table 92. Holiferm Company Information Table 93. Holiferm Business Overview Table 94. Holiferm Sophorolipid and Rhamnolipid Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Holiferm Sophorolipid and Rhamnolipid Product Portfolio Table 96. Holiferm Recent Development Table 97. Stepan Company Information Table 98. Stepan Business Overview Table 99. Stepan Sophorolipid and Rhamnolipid Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Stepan Sophorolipid and Rhamnolipid Product Portfolio Table 101. Stepan Recent Development Table 102. Jeneil Bioproducts GmbH Company Information Table 103. Jeneil Bioproducts GmbH Business Overview Table 104. Jeneil Bioproducts GmbH Sophorolipid and Rhamnolipid Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Jeneil Bioproducts GmbH Sophorolipid and Rhamnolipid Product Portfolio Table 106. Jeneil Bioproducts GmbH Recent Development Table 107. Shanxi Deguan Biotechnology Company Information Table 108. Shanxi Deguan Biotechnology Business Overview Table 109. Shanxi Deguan Biotechnology Sophorolipid and Rhamnolipid Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Shanxi Deguan Biotechnology Sophorolipid and Rhamnolipid Product Portfolio Table 111. Shanxi Deguan Biotechnology Recent Development Table 112. Shandong Qilu Biotechnology Company Information Table 113. Shandong Qilu Biotechnology Business Overview Table 114. Shandong Qilu Biotechnology Sophorolipid and Rhamnolipid Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Shandong Qilu Biotechnology Sophorolipid and Rhamnolipid Product Portfolio Table 116. Shandong Qilu Biotechnology Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Sophorolipid and Rhamnolipid Distributors List Table 120. Sophorolipid and Rhamnolipid Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Sophorolipid and Rhamnolipid Product Image Figure 2. Global Sophorolipid and Rhamnolipid Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sophorolipid and Rhamnolipid Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sophorolipid and Rhamnolipid Sales (2021-2032) & (Tons) Figure 5. Global Sophorolipid and Rhamnolipid Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Sophorolipid and Rhamnolipid Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Sophorolipid Image Figure 10. Rhamnolipid Image Figure 11. Global Sophorolipid and Rhamnolipid Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Sophorolipid and Rhamnolipid Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Sophorolipid and Rhamnolipid Sales Volume Share by Type (2021-2032) Figure 14. Global Sophorolipid and Rhamnolipid Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Sophorolipid and Rhamnolipid Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Sophorolipid and Rhamnolipid Sales Value Share by Type (2021-2032) Figure 17. Household Detergents Image Figure 18. Personal Care Image Figure 19. Industrial Image Figure 20. Food & Beverage Image Figure 21. Pharmaceuticals Image Figure 22. Others Image Figure 23. Global Sophorolipid and Rhamnolipid Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 24. Global Sophorolipid and Rhamnolipid Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Sophorolipid and Rhamnolipid Sales Volume Share by Application (2021-2032) Figure 26. Global Sophorolipid and Rhamnolipid Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Sophorolipid and Rhamnolipid Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Sophorolipid and Rhamnolipid Sales Value Share by Application (2021-2032) Figure 29. Global Sophorolipid and Rhamnolipid Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 30. Global Sophorolipid and Rhamnolipid Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Sophorolipid and Rhamnolipid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Sophorolipid and Rhamnolipid Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Sophorolipid and Rhamnolipid Sales Value (2021-2032) & (US$ Million) Figure 34. North America Sophorolipid and Rhamnolipid Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Sophorolipid and Rhamnolipid Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Sophorolipid and Rhamnolipid Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Sophorolipid and Rhamnolipid Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Sophorolipid and Rhamnolipid Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Sophorolipid and Rhamnolipid Sales Value (2021-2032) & (US$ Million) Figure 40. South America Sophorolipid and Rhamnolipid Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Sophorolipid and Rhamnolipid Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Sophorolipid and Rhamnolipid Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Sophorolipid and Rhamnolipid Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Sophorolipid and Rhamnolipid Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Sophorolipid
  • Rhamnolipid
Applications
  • Household Detergents
  • Personal Care
  • Industrial
  • Food & Beverage
  • Pharmaceuticals
  • Others
Companies covered
  • Allied Carbon Solutions
  • Saraya
  • Evonik Industries
  • Givaudan
  • Godrej Industries
  • Holiferm
  • Stepan
  • Jeneil Bioproducts GmbH
  • Shanxi Deguan Biotechnology
  • Shandong Qilu Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sophorolipid and Rhamnolipid Sales Value (2021-2032)
  4. 1.2.2 Global Sophorolipid and Rhamnolipid Sales Volume (2021-2032)
  5. 1.2.3 Global Sophorolipid and Rhamnolipid Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sophorolipid and Rhamnolipid Market Dynamics
  1. 2.1 Sophorolipid and Rhamnolipid Industry Trends
  2. 2.2 Sophorolipid and Rhamnolipid Industry Drivers
  3. 2.3 Sophorolipid and Rhamnolipid Industry Opportunities and Challenges
  4. 2.4 Sophorolipid and Rhamnolipid Industry Restraints
3 Sophorolipid and Rhamnolipid Market by Company
  1. 3.1 Global Sophorolipid and Rhamnolipid Company Revenue Ranking in 2025
  2. 3.2 Global Sophorolipid and Rhamnolipid Revenue by Company (2021-2026)
  3. 3.3 Global Sophorolipid and Rhamnolipid Sales Volume by Company (2021-2026)
  4. 3.4 Global Sophorolipid and Rhamnolipid Average Price by Company (2021-2026)
  5. 3.5 Global Sophorolipid and Rhamnolipid Company Ranking (2024-2026)
  6. 3.6 Global Sophorolipid and Rhamnolipid Company Manufacturing Base and Headquarters
  7. 3.7 Global Sophorolipid and Rhamnolipid Company Product Type and Application
  8. 3.8 Global Sophorolipid and Rhamnolipid Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sophorolipid and Rhamnolipid Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sophorolipid and Rhamnolipid Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sophorolipid and Rhamnolipid Market by Type
  1. 4.1 Sophorolipid and Rhamnolipid Type Introduction
  2. 4.1.1 Sophorolipid
  3. 4.1.2 Rhamnolipid
  4. 4.2 Global Sophorolipid and Rhamnolipid Sales Volume by Type
  5. 4.2.1 Global Sophorolipid and Rhamnolipid Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sophorolipid and Rhamnolipid Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Sophorolipid and Rhamnolipid Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Sophorolipid and Rhamnolipid Sales Value by Type
  9. 4.3.1 Global Sophorolipid and Rhamnolipid Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sophorolipid and Rhamnolipid Sales Value by Type (2021-2032)
  11. 4.3.3 Global Sophorolipid and Rhamnolipid Sales Value Share by Type (2021-2032)
5 Sophorolipid and Rhamnolipid Market by Application
  1. 5.1 Sophorolipid and Rhamnolipid Application Introduction
  2. 5.1.1 Household Detergents
  3. 5.1.2 Personal Care
  4. 5.1.3 Industrial
  5. 5.1.4 Food & Beverage
  6. 5.1.5 Pharmaceuticals
  7. 5.1.6 Others
  8. 5.2 Global Sophorolipid and Rhamnolipid Sales Volume by Application
  9. 5.2.1 Global Sophorolipid and Rhamnolipid Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Sophorolipid and Rhamnolipid Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Sophorolipid and Rhamnolipid Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Sophorolipid and Rhamnolipid Sales Value by Application
  13. 5.3.1 Global Sophorolipid and Rhamnolipid Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Sophorolipid and Rhamnolipid Sales Value by Application (2021-2032)
  15. 5.3.3 Global Sophorolipid and Rhamnolipid Sales Value Share by Application (2021-2032)
6 Sophorolipid and Rhamnolipid Regional Sales and Value Analysis
  1. 6.1 Global Sophorolipid and Rhamnolipid Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sophorolipid and Rhamnolipid Sales by Region (2021-2032)
  3. 6.2.1 Global Sophorolipid and Rhamnolipid Sales by Region: 2021-2026
  4. 6.2.2 Global Sophorolipid and Rhamnolipid Sales by Region (2027-2032)
  5. 6.3 Global Sophorolipid and Rhamnolipid Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sophorolipid and Rhamnolipid Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sophorolipid and Rhamnolipid Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sophorolipid and Rhamnolipid Sales Value by Region (2027-2032)
  9. 6.5 Global Sophorolipid and Rhamnolipid Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sophorolipid and Rhamnolipid Sales Value (2021-2032)
  12. 6.6.2 North America Sophorolipid and Rhamnolipid Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sophorolipid and Rhamnolipid Sales Value (2021-2032)
  15. 6.7.2 Europe Sophorolipid and Rhamnolipid Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sophorolipid and Rhamnolipid Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sophorolipid and Rhamnolipid Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sophorolipid and Rhamnolipid Sales Value (2021-2032)
  21. 6.9.2 South America Sophorolipid and Rhamnolipid Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sophorolipid and Rhamnolipid Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sophorolipid and Rhamnolipid Sales Value Share by Country, 2025 VS 2032
7 Sophorolipid and Rhamnolipid Country-level Sales and Value Analysis
  1. 7.1 Global Sophorolipid and Rhamnolipid Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sophorolipid and Rhamnolipid Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sophorolipid and Rhamnolipid Sales by Country (2021-2032)
  4. 7.3.1 Global Sophorolipid and Rhamnolipid Sales by Country (2021-2026)
  5. 7.3.2 Global Sophorolipid and Rhamnolipid Sales by Country (2027-2032)
  6. 7.4 Global Sophorolipid and Rhamnolipid Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sophorolipid and Rhamnolipid Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sophorolipid and Rhamnolipid Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sophorolipid and Rhamnolipid Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sophorolipid and Rhamnolipid Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sophorolipid and Rhamnolipid Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Allied Carbon Solutions
  2. 8.1.1 Allied Carbon Solutions Company Information
  3. 8.1.2 Allied Carbon Solutions Business Overview
  4. 8.1.3 Allied Carbon Solutions Sophorolipid and Rhamnolipid Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Allied Carbon Solutions Sophorolipid and Rhamnolipid Product Portfolio
  6. 8.1.5 Allied Carbon Solutions Recent Developments
  7. 8.2 Saraya
  8. 8.2.1 Saraya Company Information
  9. 8.2.2 Saraya Business Overview
  10. 8.2.3 Saraya Sophorolipid and Rhamnolipid Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Saraya Sophorolipid and Rhamnolipid Product Portfolio
  12. 8.2.5 Saraya Recent Developments
  13. 8.3 Evonik Industries
  14. 8.3.1 Evonik Industries Company Information
  15. 8.3.2 Evonik Industries Business Overview
  16. 8.3.3 Evonik Industries Sophorolipid and Rhamnolipid Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Evonik Industries Sophorolipid and Rhamnolipid Product Portfolio
  18. 8.3.5 Evonik Industries Recent Developments
  19. 8.4 Givaudan
  20. 8.4.1 Givaudan Company Information
  21. 8.4.2 Givaudan Business Overview
  22. 8.4.3 Givaudan Sophorolipid and Rhamnolipid Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Givaudan Sophorolipid and Rhamnolipid Product Portfolio
  24. 8.4.5 Givaudan Recent Developments
  25. 8.5 Godrej Industries
  26. 8.5.1 Godrej Industries Company Information
  27. 8.5.2 Godrej Industries Business Overview
  28. 8.5.3 Godrej Industries Sophorolipid and Rhamnolipid Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Godrej Industries Sophorolipid and Rhamnolipid Product Portfolio
  30. 8.5.5 Godrej Industries Recent Developments
  31. 8.6 Holiferm
  32. 8.6.1 Holiferm Company Information
  33. 8.6.2 Holiferm Business Overview
  34. 8.6.3 Holiferm Sophorolipid and Rhamnolipid Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Holiferm Sophorolipid and Rhamnolipid Product Portfolio
  36. 8.6.5 Holiferm Recent Developments
  37. 8.7 Stepan
  38. 8.7.1 Stepan Company Information
  39. 8.7.2 Stepan Business Overview
  40. 8.7.3 Stepan Sophorolipid and Rhamnolipid Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Stepan Sophorolipid and Rhamnolipid Product Portfolio
  42. 8.7.5 Stepan Recent Developments
  43. 8.8 Jeneil Bioproducts GmbH
  44. 8.8.1 Jeneil Bioproducts GmbH Company Information
  45. 8.8.2 Jeneil Bioproducts GmbH Business Overview
  46. 8.8.3 Jeneil Bioproducts GmbH Sophorolipid and Rhamnolipid Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jeneil Bioproducts GmbH Sophorolipid and Rhamnolipid Product Portfolio
  48. 8.8.5 Jeneil Bioproducts GmbH Recent Developments
  49. 8.9 Shanxi Deguan Biotechnology
  50. 8.9.1 Shanxi Deguan Biotechnology Company Information
  51. 8.9.2 Shanxi Deguan Biotechnology Business Overview
  52. 8.9.3 Shanxi Deguan Biotechnology Sophorolipid and Rhamnolipid Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shanxi Deguan Biotechnology Sophorolipid and Rhamnolipid Product Portfolio
  54. 8.9.5 Shanxi Deguan Biotechnology Recent Developments
  55. 8.10 Shandong Qilu Biotechnology
  56. 8.10.1 Shandong Qilu Biotechnology Company Information
  57. 8.10.2 Shandong Qilu Biotechnology Business Overview
  58. 8.10.3 Shandong Qilu Biotechnology Sophorolipid and Rhamnolipid Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Shandong Qilu Biotechnology Sophorolipid and Rhamnolipid Product Portfolio
  60. 8.10.5 Shandong Qilu Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sophorolipid and Rhamnolipid Value Chain Analysis
  2. 9.1.1 Sophorolipid and Rhamnolipid Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sophorolipid and Rhamnolipid Sales Mode & Process
  6. 9.2 Sophorolipid and Rhamnolipid Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sophorolipid and Rhamnolipid Distributors
  9. 9.2.3 Sophorolipid and Rhamnolipid Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst